Garbo Valeria, Venuti Laura, Boncori Giovanni, Albano Chiara, Condemi Anna, Natoli Giuseppe, Frasca Polara Valentina, Billone Sebastiano, Canduscio Laura Antonella, Cascio Antonio, Colomba Claudia
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, 90127 Palermo, Italy.
Antibiotics (Basel). 2024 Dec 7;13(12):1192. doi: 10.3390/antibiotics13121192.
Infections caused by S. aureus strains encoding Panton-Valentine leukocidin (PVL-SA) have become increasingly relevant in community settings and can cause severe conditions in pediatric populations. We present the pediatric case of an invasive disease caused by PVL-SA and provide a literature review of severe manifestations caused by these strains in children. : A PubMed search (February 2024) found studies that included relevant clinical outcomes, diagnostics, and treatments, excluding cases of asymptomatic infection or in adult populations. A logistical multivariate analysis was used to find predictors of the need for intensive care. : A 10-year-old boy came to the attention of our Pediatric Infectious Diseases Unit with fever, chest pain, and tachypnea. A rapid worsening of his clinical conditions was observed, with the development of necrotizing pneumonia, osteomyelitis, deep vein thrombosis (DVT), and multiple abscesses. Blood cultures confirmed the presence of PVL-producing methicillin-resistant (MRSA). The initial treatment included linezolid and ceftaroline and was later adjusted to clindamycin, daptomycin, and fosfomycin, with clinical improvement. : Our review collected 36 articles, including 156 pediatric cases of severe PVL-SA infection. Bacteremia was present in 49% of cases, lung infection in 47%, and osteomyelitis in 37%. The presence of pulmonary localization was predictive of the need for intensive care, O.R. 25.35 (7.46-86.09; < 0.001). Anti-toxin molecules were used in about half the cases where information on treatment was reported. Our report highlights the capacity of PVL-SA to cause life-threatening complications in children, while also discussing the full range of its clinical spectrum and the most effective therapeutic approaches.
由编码杀白细胞素(PVL)的金黄色葡萄球菌菌株(PVL-SA)引起的感染在社区环境中变得越来越普遍,并且可在儿科人群中导致严重病症。我们报告了1例由PVL-SA引起的侵袭性疾病的儿科病例,并对这些菌株在儿童中引起的严重表现进行文献综述。方法:通过PubMed检索(2024年2月),查找纳入了相关临床结局、诊断和治疗方法的研究,排除无症状感染病例或成人病例。采用多因素logistic分析确定重症监护需求的预测因素。结果:一名10岁男孩因发热、胸痛和呼吸急促就诊于我们的儿科传染病科。观察到其临床状况迅速恶化,出现坏死性肺炎、骨髓炎、深静脉血栓形成(DVT)和多处脓肿。血培养证实存在产PVL的耐甲氧西林金黄色葡萄球菌(MRSA)。初始治疗包括利奈唑胺和头孢洛林,后来调整为克林霉素、达托霉素和磷霉素,临床症状有所改善。结论:我们的综述收集了36篇文章,包括156例严重PVL-SA感染的儿科病例。49%的病例存在菌血症,47%存在肺部感染,37%存在骨髓炎。肺部定位是重症监护需求的预测因素,比值比为25.35(7.46 - 86.09;P < 0.001)。在约一半报告了治疗信息的病例中使用了抗毒素分子。我们的报告强调了PVL-SA在儿童中引发危及生命并发症的能力,同时也讨论了其完整的临床谱和最有效的治疗方法。